Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, randomized, placebo-controlled study
- 30 April 2012
- journal article
- research article
- Published by Elsevier BV in Metabolism
- Vol. 61 (4), 577-582
- https://doi.org/10.1016/j.metabol.2011.09.008
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Walnut Consumption Increases Satiation but Has No Effect on Insulin Resistance or the Metabolic Profile Over a 4‐day PeriodObesity, 2010
- Nuts, metabolic syndrome and diabetesBritish Journal of Nutrition, 2010
- Comparison of Multiplex Immunoassay PlatformsClinical Chemistry, 2010
- Dietary patterns and incident cardiovascular disease in the Multi-Ethnic Study of AtherosclerosisThe American Journal of Clinical Nutrition, 2009
- Effects of walnut consumption on blood lipids and other cardiovascular risk factors: a meta-analysis and systematic reviewThe American Journal of Clinical Nutrition, 2009
- Nuts and health outcomes: new epidemiologic evidenceThe American Journal of Clinical Nutrition, 2009
- Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin ProductionPLOS ONE, 2008
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJCI Insight, 2006
- Adiponectin and cancer: a systematic reviewBritish Journal of Cancer, 2006